Summary.-The effects of cis-dichlorodiammine platinum II (DDP) on the intestinal mucosa and the kidney were studied after single and multiple treatments with intervals of 7-45 days. After a single treatment, the jejunal epithelium underwent a transient interruption of cell proliferation followed by a hyperplastic recovery and return to control proliferative rate on Day 7. Subsequent treatments led to suboptimal recovery for all treatment intervals. In contrast, DDP induced a 6-fold increase in [3H]dT incorporation in the kidney by Day 7 which remained high until Day 21, and returned to near-control values by Day 45. After a single DDP treatment, the "recovery potential" of kidneys, measured by the proliferative response to folic-acid stress, demonstrated suboptimal proliferative reserve compartments for up to 45 days. The distinction between acute and delayed sensitivity to subsequent drug treatment was more apparent in the DDP-treated kidney than in the intestinal epithelium.
CIS-DICHLORODIAMMINE PLATINUA II (DDP) has been reported to be effective against a number of tumours in animals (Welsch, 1971; Douple et al., 1977; Presnov et al., 1978) and in man (Higby et al., 1974; Wallace & Higby, 1974; Yagoda et al., 1978) .
The most serious toxic side-effects result from damage to the renal tubules (the dose-limiting tissue in man), the gastrointestinal epithelium and the marrow (Taylor et al., 1976; Gonzales-Vitale et al., 1977; Presnov et al., 1978; Lehane et al., 1979) .
The use of chemotherapeutic agents such as DDP in regimens designed (1) to recruit additional non-proliferating neoplastic cells into the cell cycle, (2) to modify the cycling characteristics (e.g. synchronize), or (3) to enhance tumour cytotoxicity by multiple treatments may also produce unforeseen damage to the dose-limiting organs and cells of rapidly proliferating normal tissues. These toxicities usually occur either early after treatment (acute) or are delayed. More recently, toxicities of a subelinical nature have been defined (Dentino et al., 1978; Freeman et al., 1979; Bruno et al., 1980) which are very often manifestations of transient or long-lasting reduction in proliferative reserves of the normal cell-renewal systems. In the present studies we have investigated the proliferative reserve of both the gastrointestinal and renal-tuble epithelium after single and sequential treatments with DDP.
MATERIALS AND METHODS

A nimal treatment
Male BDF1 mice (Jax) used throughout these studies w-ere housed, 5 mice/cage, in animal quarters -with a 12 h photoperiod.
Mice were fed standard mouse chow (Purina, Evanston, Ill.) Orangeburg, N.Y.) . Thirty minutes later, the mice were killed and 4 cm segments of jejunum and both kidneys were removed. Immediately after excision, tissue were placed in iced saline. The tissues were cleaned, the jejunum slit to remove luminal contents, rinsed in saline, blotted to remove adherent moisture and weighed. The left kidney was fixed in buffered formalin, embedded in paraffin and 4,um sections prepared for autoradiography (ARG) using Kodak NTB-2 emulsion. The slides were exposed at 4°C for 21 days and developed with Kodak D-19. The ARGs were stained through the emulsion with haematoxylin and counterstained with acidified eosin and coverslipped. For microscopic analysis, a cell was considered labelled if it contained 5 or more grains per nucleus. Labelling indices (LI) were determined by counting at least 3000-5000 cells in the renal cortex. The labelled fraction was expressed as a percentage. The mean grain count of labelled cells was > 25 grains per cell. Glomerular, medullary and interstitial cells were not counted. The local background for the ARGs was 2-3 grains per cell.
The right kidney and the jejunal segment were fixed in 3: 1 absolute alcohol: acetic acid for 24 h, which removes unincorporated label (Burholt et al, 1977) . The tissues were then solubilized in Soluene (New England Nuclear, Boston, MA) and the radioactivity counted in a liquid-scintillation spectrometer with internal quench correction and absolute activity analyser. The results for the intestine were expressed on a tissue-weight basis (d/min/mg wet wt) while the results for the kidney were expressed on an organ basis (d/min/kidney). Kidney.-The renal -response deficit (RRD) was estimated by the integrated cell production after 100 mg/kg FA given at various times after DDP treatment as a percentage of that after 100 mg/kg FA in untreated kidneys. The ratios for cell production measured by both ct/min/kidney and LI were compared. was noted up to 36 h with subsequent compensatory hyperplasia between 48 and 144 h ( Fig. 1 ). Cell production then returned to control levels (7 days) and remained so throughout the next 38 days of observation. Unlike the intestine, the kidney, normally associated with low rates of cell production, was not immediately affected by a single injection of DDP. Within 48 h of treatment, however [3H]dT incorporation into the kidney gradually increased, reaching a maximum (740% of untreated control) on Day 7 (Fig. 1) . Proliferation gradually returned to nearly control levels by Day 45 (145% of control).
Sequential treatment with 8 my/kg DDP After the initial DDP treatment, a second dose of 8 mg/kg DDP was given to animals on Days 7, 14, 21 or 45. Intestinal proliferation at the time of the second treatment had returned to control levels. Recovery after the second DDP treatment was subnormal at all intervals up to 45 days (Fig. 2) . Proliferative peaks after the second treatment occurred earlier (72 h) and were lower. Cell production over the 120 h period after treatment on Days 0 + 7 and Days 0 + 45 was about 65% of that after a single treatment, whilst for Days 0+14 and Days 0+21, cell production was 80% of groups receiving a single treatment (Table I) .
Unlike the intestine, the proliferative activity in the kidney at the time of the second treatment was higher than control, untreated levels (Fig. 3) (Fig. 4) , the renal response to FA stress demonstrated a subnormal proliferative reserve for all intervals studied up to day 45 after DDP treatment.
If all tubular cells that took up [3H]dT were subsequently to divide, the area under the d/min/kidney and LI timecourse curves would be proportional to the total cell production during the experiments. Table II illustrates the changes in net cell production induced by FA as a function of the time after an initial DDP treatment. In general, the magnitude of cell production estimated from the LI curve was greater than that estimated by d/min/kidney. However, the relative deficits in integrated cell production calculated from these two indices were similar. The response deficits on Days 7 and 21 were similar. However, on Day 14 the response deficit was at a minimum, separating acute DDP renal effects from a significant and progressively increasing long-term reduction in renal proliferative reserve.
DISCUSSION
The results from these studies demonstrate the response of two different normal tissues to cis-platinum II. In the rapidly proliferating intestinal epithelium, DDP produces a transient inhibition of cell production, followed by a compensatory recovery and a return to steady-state control levels 7 days after treatment (Fig.  1) . The time course and magnitude of this response have been found to be dosedependent (Phillips & Fu, 1976; Burholt et a., 1979; Luk et al., 1979) , suggesting that the drug alone is cytotoxic to the intestinal crypt cells. In addition, DDP has been found to enhance the gastrointestinal radiosensitivity in combined radiation+drug studies (Luk et al., 1979; Schenken et al., 1979a) .
By comparison, renal-tubule cell proliferation is not markedly affected by DDP treatment (Fig. 1) . Incorporation of [3H]dT is only slightly depressed during the first 24 h after treatment, increasing after 3 days and reaching a 6-fold increase on Day 7. Taylor et al. (1976) have reported similar observations in rats treated with 4 0 mg/kg DDP. However, they observed an initial marked inhibition of DNA synthesis before a 16-fold increase by Day 7. Cell proliferation in the kidney under non-stress conditions as monitored by d/min/kidney reflects proliferation of transitional and squamous epithelium rather than tubular epithelium, which is extremely low. This may explain the discrepancy between the initial renal response to DDP reported here and that observed by Taylor et al. (1976) . In addition, there may be interspecific differences in drug dose as suggested by Litterst et al. (1979) .
Treatments after the first dose of DDP led to suboptimal recovery of the jejunal epithelium for intertreatment times up to 45 days (Fig. 2) . Both the magnitude and time of compensatory proliferative peaks were reduced. While steady-state proliferative conditions were restored by Day 7, the response deficits calculated for subsequest treatments up to 45 days (Table I) suggested that DDP in sequential protocols would enhance the intestinal drug sensitivity. Second treatments on Days 7 or 45 were less well tolerated than those on Days 14 or 21. Similar enhanced drug sensitivity was found in the kidney after an initial treatment with DDP (Figs 4 & 5; Table II) . Again a subsequent treatment on Day 14 appeared more tolerable than after the other treatment intervals. In the kidney, the distinction between early (acute) and delayed enhancement of sensitivity was more apparent.
Delayed complications after both drug and radiation therapy have been recognized in a number of normal tissues (Phillips & Fu, 1976; Nygaard et al., 1976) . Schenken et al. (1979b) , have recently demonstrated enhanced gastrointestinal radiosensitivity by Adr, where the drug and radiation treatments were separated by 14-49 days. Similarly to our observations for sequential drug treatment, they observed that radiosensitivity diminished from the time of drug treatment until 14 days, and then progressively increased in severi-ty for up to 49 days. Enhanced tissue sensitivity, when intertreatment times are short is probably a direct result of the interaction of the treatment modalities on the cell-proliferation kinetics of the tissue. Enhanced sensitivity arising from longer treatment intervals, however, is most probably a manifestation of reduced proliferative reserves in the normal cell-renewal systems (Schenken et al., 1979b; Braunschweiger et al., 1980; Morley, 1980) . Dentino et al. (1978) have reported permanent, nonspecific functional renal injury in patients treated with DDP. They suggested that ". . . while renal injury remained subclinical, future courses of DDP could lead to clinically important renal failure". From the results presented here, increasing the intertreatment time from 7 to 14 days appeared to permit proliferative recovery of the renal tissue (Fig. 3) (Taylor et al., 1976 ) with significant levels retained tightly bound to tissue protein and nucleic-acid bases (Taylor et al., 1973) . This could explain the apparent recovery of early damage (Days 0-14) shown in Fig. 5 , where near-normal levels of cell production (87%; Table II) occur after FA stress. However, if drug retention alone were responsible for the reductions in proliferative reserve, and near-normal responses occurred at Day 14 after drug treatment, similar or even improved responses to FA would be expected on Days 21 and 45. Rather it appears that a secondary effect, not related to the immediate drug inhibition of the proliferative reserve, develops at these later times, and has been found up to 120 days after the initial treatment (Braunschweiger et al., 1980, and unpublished) .
One could argue that when the kidney undergoes proliferative recovery, the cell population of the proliferative reserve is reduced, thus reducing the overall ability of the tissue to respond to further proliferative stress. Experimentally induced renal hypertrophy has, however, been extensively studied in both mice and rats (Baserga et al., 1968; Byrnes et al., 1972a,b) and these data suggest that the kidney is capable of responding to a second stress stimulus (Threlfall et al., 1967) . Alternatively, long-term exposure to even low levels of drug could permanently damage the renal microenvironment, which in turn could have a net antiproliferative effect. Dentino et al. (1978) have observed a regular and persistent decrease in the glomerular filtration rate of patients after the second course of DDP; they noted segmental cellular necrosis in the proximal and distal tubules at 3-6 weeks after treatment, and after 5 months focal interstitial fibrosis was evident as well as tubular atrophy and dilation.
It is as yet unclear whether the underlying mechanisms of the long-term toxicities from DDP treatment are similar for intestinal and renal-tubular epithelium. However, from a clinical standpoint, the answer to such a question takes on new importance, especially for continuing or recurring therapy. Studies are continuing to elucidate the nature of, and amelioration of, these potentially harmful effects.
